Cardiovascular diseases including coronary heart disease, stroke and heart failure are by far the main causes of mortality and morbidityamong people with type 2 diabetes Even though, the existence of both diabetes and cardiovascular diseases are usually provoked by obesity and insulin resistance, a good percentage of people with cardiovascular disease are either having type 2 diabetes or pre-diabetes There is a crucial need for treating diabetes , hypertension , obesity and all cardiovascular risk factors aiming to optimize the overall outcome , cost wise , it is estimated that 1-year cardiometabolic disease resulted from improper diet in the USAamongst those aged 35–85 years may reach $50.4 billion . Some new pharmacological therapies may help in optimizing the cardiometabolic outcome. the most recent cardiovascular outcome trials (CVOTs) concluded that glucagon-like peptide-1 (GLP-1) receptor agonists as well as sodium-glucose transporter 2 (SGLT2) inhibitors may significantly reduce the major cardiovascular events and proved also to be effective in lowering the blood glucose levels. Recent literature reviewing indicated that the incidence of cardiovascular diseases are on the decline over time The management of these cardiometabolic risk factors may warrant the need for a new specialty namely the Cardiometabolic Medicine. This three-days, CME-certified activity will look at the Cardiometabolic risk factors from different angles including but not limited to hypoglycemia, Diabetes Self-management Education, Insulin, Continuous glucose monitoring (CGM), Technology and data from recent large clinical trials reported low risk of the cardiovascular events with the use of newer drugs like glucagon-like peptide-1 (GLP-1) receptor agonists as well as sodium-glucose transporter 2 (SGLT2) inhibitors. In keeping the expected ~1000 attendees the lectures, workshops and case studies will be presented by high caliber international speakers. The conference will collaborate with one of the most important conferences addressing the cardiometabolic medicine, the 5th Heart in Diabetes Conference, both big events will be conducted simultaneously 10-12 September 2021. The sessions will be streamed live and the attendees will be able to access the full lectures contents one month after.

Looking forward to welcoming you !